These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34157125)

  • 1. Efficacy and Safety of Intravenous Pamidronate for Parathyroid Hormone-dependent Hypercalcemia in Hospitalized Patients.
    Rosenblum RC; Twito O; Barzilay-Yoseph L; Ramaty E; Klein N; Rotman-Pikielny P
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4593-e4602. PubMed ID: 34157125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
    Demir K; Döneray H; Kara C; Atay Z; Çetinkaya S; Çayır A; Anık A; Eren E; Uçaktürk A; Can Yılmaz G; Törel Ergür A; Kendirci M; Aycan Z; Bereket A; Aydın M; Orbak Z; Özkan B
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):140-148. PubMed ID: 30396880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.
    Cvitkovic F; Armand JP; Tubiana-Hulin M; Rossi JF; Warrell RP
    Cancer J; 2006; 12(1):47-53. PubMed ID: 16613662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages.
    Nussbaum SR; Younger J; Vandepol CJ; Gagel RF; Zubler MA; Chapman R; Henderson IC; Mallette LE
    Am J Med; 1993 Sep; 95(3):297-304. PubMed ID: 8368227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia: A Review.
    Walker MD; Shane E
    JAMA; 2022 Oct; 328(16):1624-1636. PubMed ID: 36282253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral hypercalcemia of pregnancy treated with bisphosphonates.
    Koren R; Neeman O; Koren S; Benbassat CA
    Arch Endocrinol Metab; 2018 Feb; 62(1):125-128. PubMed ID: 29694631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
    Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
    Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current management strategies for hypercalcemia.
    Pecherstorfer M; Brenner K; Zojer N
    Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
    Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
    Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Pamidronate to Treat Hypercalcemia in an Oncology Dialysis Patient: A Case Report.
    Mahmoud S; Mitwally H; El Zeer HS; El Madhoun I; Khatib M
    Am J Case Rep; 2018 Sep; 19():1087-1089. PubMed ID: 30209247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
    Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
    Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction.
    Palmer S; Tillman F; Sharma P; Auten J; Owen K; Clark SM; Morgan KP
    Ann Pharmacother; 2021 Mar; 55(3):303-310. PubMed ID: 32847379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pamidronate in the management of acute cancer-related hypercalcemia in children.
    Young G; Shende A
    Med Pediatr Oncol; 1998 Feb; 30(2):117-21. PubMed ID: 9403021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia.
    Sabour S; Manders E; Steward DL
    Otolaryngol Head Neck Surg; 2009 Dec; 141(6):727-9. PubMed ID: 19932845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative Parathyroid Hormone Monitoring in Parathyroidectomy for Tertiary Hyperparathyroidism.
    Ermer JP; Kelz RR; Fraker DL; Wachtel H
    J Surg Res; 2019 Dec; 244():77-83. PubMed ID: 31279997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the antihypercalcemic drugs gallium nitrate and pamidronate on hormone release of pathologic human parathyroid cells.
    Ridefelt P; Gylfe E; Akerström G; Rastad J
    Surgery; 1995 Jan; 117(1):56-61. PubMed ID: 7809837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.